RadarNCT07677735
Non-contact Patient Monitoring With Millimeter Wave Radar Technology.
A study testing monitoring physiological and movement-based data in people with Radar and Monitoring, run by Rukiye Kokkiz.
Trial summary
This study aims to develop a millimeter wave radar technology-based patient monitoring system that allows for the monitoring of physiological and movement-based data in healthcare settings without requiring physical contact with individuals. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Radar, Monitoring, Physiologic Monitoring
- What is being tested?
- monitoring physiological and movement-based data
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 6 participants
- Where
- No sites listed yet
- Study dates
- 1 Aug 2026to 1 Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Participating in the research as a researcher
Who cannot join
- Wanting to withdraw from the research
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Development of a Contactless Patient Monitoring System Using Millimeter Wave Radar Technology
This study aims to develop a millimeter wave radar technology-based patient monitoring system that allows for the monitoring of physiological and movement-based data in healthcare settings without requiring physical contact with individuals. The study will involve the creation of hardware and software components for processing, analyzing, and converting signals obtained through radar sensors into clinically meaningful data.
- Conditions
- Radar, Monitoring, Physiologic Monitoring
- Being tested
- monitoring physiological and movement-based data
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
monitoring physiological and movement-based dataDevice
monitoring physiological and movement-based data
| Study group | Role | What they receive |
|---|---|---|
| Data collection with the prototype device. | Other | The developed prototype device will collect respiratory rate, heart rate, blood pressure, and cardiac output data from six healthy individuals acting as researchers. Receives: Device: monitoring physiological and movement-based data |
What is being measured
The primary outcome is the main question the study is designed to answer.
Data collection with the prototype device.
The developed prototype device will collect respiratory rate, heart rate, blood pressure, and cardiac output data from six healthy individuals acting as researchers.
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jul 2026
- Study start1 Aug 2026 (estimated)
- Primary completion1 Sep 2026 (estimated)
- Study completion1 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for RadarStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 6 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Rukiye Kokkiz
- Sponsor type
- University, hospital or other
- Collaborators
- Health Institutes of Turkey
- Responsible party
- Sponsor-investigator, Rukiye Kokkiz, Fenerbahce University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07677735
- Sponsor's protocol ID
- 55754-1 TUSEB
- Status last verified
- Jun 2026
- First submitted
- 18 Jun 2026
- Last updated
- 1 Jul 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Development of a Contactless Patient Monitoring System Using Millimeter Wave Radar Technology
- ClinicalTrials.gov ID
- NCT07677735
- Acronym / sponsor ID
- 55754-1 TUSEB
- Conditions
- Radar, Monitoring, Physiologic Monitoring
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 6 participants (estimated)
- Lead sponsor
- Rukiye KokkizUniversity, hospital or other
- Collaborators
- Health Institutes of Turkey
- Study start
- 1 Aug 2026 (estimated)
- Primary completion
- 1 Sep 2026 (estimated)
- Study completion
- 1 Oct 2026 (estimated)
- First posted
- 1 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to develop a millimeter wave radar technology-based patient monitoring system that allows for the monitoring of physiological and movement-based data in healthcare settings without requiring physical contact with individuals. The study will involve the creation of hardware and software components for processing, analyzing, and converting signals obtained through radar sensors into clinically meaningful data.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Data collection with the prototype device. | Other | Device: monitoring physiological and movement-based dataThe developed prototype device will collect respiratory rate, heart rate, blood pressure, and cardiac output data from six healthy individuals acting as researchers. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Participating in the research as a researcher
Key exclusion criteria (1 listed)
- Wanting to withdraw from the research
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| monitoring physiological and movement-based datamonitoring physiological and movement-based data | Device | Data collection with the prototype device. |
Primary outcome
Data collection with the prototype device.
Time frame: 3 months
The developed prototype device will collect respiratory rate, heart rate, blood pressure, and cardiac output data from six healthy individuals acting as researchers.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jul 2026.
Related trials for Radar
RecruitingObservational study
Development of a Multimodal Deep Learning Model for Pediatric Patients
Pediatric Obstructive Sleep Apnea, Polysomnography
Recruiting
Radon on the RADAR (Residents Acting to Detect and Alleviate Radon) 2.0
Radon Exposure
Recruiting
Study Comparing Hemiarch Replacement and Hemiarch Plus Stent Implantation in Acute Aortic Dissection
Aortic Dissection
Not yet recruitingObservational study
Deep-learning Predictors of Abdominal Aortic Aneurysm Enlargement in Type II Endoleaks After Endovascular Aortic Repair: The RADAR Study
Type II Endoleak, Abdominal Aortic Aneurysm Enlargement
Not yet recruitingPhase 3
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
Hypertension, Hypertension,Essential
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing monitoring physiological and movement-based data in people with Radar and Monitoring, run by Rukiye Kokkiz.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 1 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact RUKİYE KOKKIZ, LECTURER (+90 507 140 68 98, rky_kokkiz@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Data collection with the prototype device. (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2026.